ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 855

Identification of a Burkholderia-Like Strain From Temporal Arteries of Subjects with Giant Cell Arteritis

Curry L. Koening1, Bradley J. Katz2, Jose Hernandez-Rodriguez3, Marc Corbera-Bellalta4, Maria C. Cid5, Herbert P. Schweizer6, Dean Li2, Jerry Kaplan2, Gary S. Hoffman7 and Ivana De Domenico8, 1Internal Medicine, Salt Lake City Veterans Administration, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT, 3Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 4Systemic Autoimmune Diseases, Vasculitis Research Unit. Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 5Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, 6Colorado State University, Fort Collins, CO, 7Rheumatic & Immunologic Dis, Cleveland Clinic, Cleveland, OH, 8Internal Medicine-Division of Rheumatology, University of Utah, Salt Lake City, UT

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: giant cell arteritis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis: Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries. An infectious organism has been hypothesized to cause GCA. We used 16S rRNA analysis to amplify a bacterial genomic sequence unique to the temporal arteries of GCA subjects. Identification of the bacteria allowed us to detect the organism’s lipopolysaccharide (LPS) in the serum of these subjects and isolate the bacteria from temporal arteries of GCA patients. 

Methods:

Frozen and paraffin-embedded temporal arteries from biopsy-proven GCA subjects and controls were used for analysis.  GCA subjects fulfilled the 1990 ACR criteria for GCA.  DNA and RNA were isolated from frozen temporal arteries. 16S rRNA analysis was performed using primers to the conserved regions of bacterial 16S rRNA. Multilocus sequence typing (MLST), a PCR-based method of bacterial identification, was performed to type the organism.  A Burkholderia anti-LPS monoclonal antibody was used to perform immunofluorescence (IF) and ELISA.  Burkholderia was cultured from a temporal artery and the isolate was injected into C3H/HeSnJ mice. Infected mice were sacrificed and organs were analyzed by light microscopy for vasculitis.  Student’s t-test was used to compare mean values. 

Results:

16S rRNA analysis identified a genomic sequence within an affected artery that was 100% homologous to the genus Burkholderia.  Primers specific for the bacteria identified the organism in 9/10 GCA arteries but in none of the controls (0/11).  MLST analysis identified the organism as B. pseudomallei-like (BpGCA).  RT-PCR confirmed the absence of type III secretion factors, a genetic profile that confers an attenuated phenotype for many species of Burkholderia. IF of paraffin-embedded temporal arteries identified BpGCA-LPS in GCA arteries but not controls.  ELISA detected BpGCA-LPS at high levels in the serum of GCA subjects (n=61, mean 437.8 pg/ml, SEM 36.7) but not healthy controls (n=102, mean 28.1 pg/ml, SEM 3.8, p<0.0001).  BpGCA was cultured from the temporal artery of a subject with GCA and the isolate was used to infect C3H/HeSnJ mice. Mice injected with the organism developed inflammation of pulmonary blood vessels.

Conclusion:

An attenuated newly identified species of Burkholderia has been isolated from temporal arteries of GCA subjects.  LPS of the organism is detectable in the serum of GCA subjects. Mice infected with the organism develop vasculitis. BpGCA appears to be a critical factor in the pathogenesis of GCA.


Disclosure:

C. L. Koening,
None;

B. J. Katz,
None;

J. Hernandez-Rodriguez,
None;

M. Corbera-Bellalta,
None;

M. C. Cid,
None;

H. P. Schweizer,
None;

D. Li,
None;

J. Kaplan,
None;

G. S. Hoffman,
None;

I. De Domenico,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-a-burkholderia-like-strain-from-temporal-arteries-of-subjects-with-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology